IFG
SRNE

Independent Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Independent Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34,500
Closed -$30.6K – 891
2022
Q4 		$30.6K Sell
34,500
-12,500
-27% -$16.6K ﹤0.01% 773
2022
Q3 		$73.8K Buy
47,000
+3,000
+7% +$6.8K 0.01% 722
2022
Q2 		$88.4K Hold
44,000
– – 0.01% 682
2022
Q1 		$103K Buy
44,000
+500
+1% +$1.56K 0.01% 757
2021
Q4 		$202K Buy
43,500
+5,500
+14% +$34.1K 0.02% 730
2021
Q3 		$290K Buy
38,000
+7,000
+23% +$59.4K 0.03% 537
2021
Q2 		$300K Buy
31,000
+17,000
+121% +$135K 0.03% 533
2021
Q1 		$116K Buy
14,000
+4,000
+40% +$42.2K 0.02% 625
2020
Q4 		$68.3K Buy
+10,000
New +$80.3K 0.01% 556

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Independent Financial Group's SRNE Position: Q1 2023 in Review

Independent Financial Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 34,500 shares — an estimated $30.6K sold.

Independent Financial Group first reported a position in SRNE in Q4 2020 and held it in 9 quarters. The position peaked at $300K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Independent Financial Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Independent Financial Group sold 34,500 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $30.6K.
  • Independent Financial Group first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 9 quarters.
  • Independent Financial Group's Sorrento Therapeutics, Inc. position peaked at $300K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Independent Financial Group's 13F filing for Q1 2023, filed 12 Jun 2026.